Abstract FZJ-2022-03904

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Combining advanced MRI and PET



2022

EAN 2022 – Vienna, ViennaVienna, Austria, 25 Jun 2022 - 25 Jun 20222022-06-252022-06-25

Abstract: ABSTRACTNeuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) provide valuable diagnostic information in the follow-up of patients with glioma. Particularly PET using radiolabeled amino acids, advanced MRI techniques such as perfusion-weighted imaging, diffusion-weighted imaging or MR spectroscopy, and combinations thereof demonstrated their potential for a non-invasive assessment of biological characteristics of brain cancer. Considering the growing complexity of neuroimaging data, advanced statistical methods from the field of artificial intelligence such as radiomics play an important role for clinical decision-making and have the potential to significantly impact diagnosis and response assessment in neuro-oncology. Further, the increasing availability of hybrid PET/MRI systems and the advent of ultra-high field MRI scanners operating at magnetic field strengths of 7 Tesla or more opens new possibilities for improvements in metabolic imaging. The presentation summarizes the status of advanced MRI and PET, highlights the latest developments and methodological advancements, and envisions the future role of advanced neuroimaging in the follow-up of patients with glioma.


Contributing Institute(s):
  1. Physik der Medizinischen Bildgebung (INM-4)
Research Program(s):
  1. 5253 - Neuroimaging (POF4-525) (POF4-525)

Appears in the scientific report 2022
Click to display QR Code for this record

The record appears in these collections:
Document types > Presentations > Abstracts
Institute Collections > INM > INM-4
Workflow collections > Public records
Publications database

 Record created 2022-10-27, last modified 2022-10-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)